Selected Publications:
Schneider, J.E., Miller, T.R., Ohsfeldt, R.L., Morrisey, M.A., Zelner, B.A., and Li, P., “The Economics of Specialty Hospitals,” Medical Care Research and Review (forthcoming).
Wehby, G.L., Ohsfeldt, R.L., and Murray, J.C., “Mendelian Randomization Equals Instrumental Variable Analysis with Genetic Instruments," Statistics in Medicine (forthcoming).
Ohsfeldt, R.L., Gandhi, S.K., Fox, K.M., and McKenney, J.M., “Statin Cost-effectiveness Comparisons Using Real-world Effectiveness Data: Formulary Implications,” Value in Health (forthcoming).
Ohsfeldt, R.L., Lage, M.J., and Rajagopalan, K., “Medication Use, Service Utilization and Medical Costs Associated with New Episodes of Bipolar Disorder: Evidence from a Retrospective Claims Database,” Primary Care Companion to the Journal of Clinical Psychiatry (forthcoming).
Fox, K.M, Gandhi, S.K., and Ohsfeldt, R.L., “Comparison of Low Density Lipoprotein-Cholesterol (LDL-C) Reduction after Switching Patients on Other Statins to Rosuvastatin or Simvastatin in a Real-World Clinical Practice Setting,” American Journal of Managed Care 13 [December 2007]: S270-S275.
Fox, K.M., Gandhi, S.K., Ohsfeldt, R.L., Blasetto, J.W., and Davidson, M.H., “Titration Patterns with Rosuvastatin as Compared to Other Statins in Clinical Practice: Retrospective Cohort Study Using an Electronic Medical Record Database,” Clinical Therapeutics 29 [November 2007]: 2385-2394.
Shaya, F.T. and Ohsfeldt, R.L., “Bridging the Gap Between Pharmacoeconomics and the Real World Practice of Managed Care Pharmacy,” Journal of Managed Care Pharmacy, 2007;13(1): 66-67.
Fox, K.M, Gandhi, S.K., Ohsfeldt, R.L., Blasetto, J.W., and Davidson, M.H., “Effectiveness of Statins in Medicare-eligible Patients and Patients <65 Years using Clinical Practice Data,” International Journal of Clinical Practice 61 [October 2007]: 1634-1642.
Fox, K.M., Gandhi, S.K., Ohsfeldt, R.L., Blasetto, J.W., and Bays, H.E., “Effectiveness of Statins in Low-density Lipoprotein Cholesterol Lowering and National Cholesterol Education Program Adult Treatment Panel Guideline III LDL-C Goal Attainment among Diabetes Mellitus Patients: A U.S. Retrospective Analysis,” Current Medical Research and Opinion 23 [September 2007]: 2125-2133.
Schneider, J.E., Ohsfeldt, R.L., Li, P., Miller, T.R., Morrisey, M.A. and Zelner, B.A., “The Effects of Specialty Hospitals on General Hospital Financial Performance, 1997-2004,” Inquiry 44 [Fall 2007]: 321-334.
Ohsfeldt, R.L., Lage, M.J., and Rajagopalan, K., “Medication Use, Service Utilization and Medical Costs Associated with New Episodes of Bipolar Disorder: Evidence from a Retrospective, Claims Database,” Primary Care Companion to the Journal of Clinical Psychiatry 9 [August 2007]: 280–286.
Wehby, G.L. and Ohsfeldt, R.L., “Impact of Having a Young Child with Disabilities on Maternal Labor Supply,” Journal of Health and Human Services Administration 30 [Winter 2007]: 327-351.
Ohsfeldt, R.L., Gandhib, S., Fox, K., Stacy, T., and, J. McKenney, J., "Effectiveness and Cost-Effectiveness of Rosuvastatin, Atorvastatin and Simvastatin among High Risk Patients in Usual Clinical Practice," American Journal of Managed Care 2006;12(15, Suppl): S412-S423.
Balamurugan, A., Ohsfeldt, R., Hughes, T., Phillips, P., “Diabetes Self-Management Education for Medicaid Recipients: A Continuous Quality Improvement Process,” Diabetes Educator 2006;32(6):893-900.
Ohsfeldt, RL, & JE Schneider. 2006. The Business of Health: The Role of Competition, Markets, and Regulation. Washington DC: AEI Press
Wehby G, Ohsfeldt R, Murray J. "Health Professionals' Assessment of Health-Related Quality of Life Values for Oral Clefting by Age Using a Visual Analogue Scale Method," Cleft Palate-Cran J 2006;43(4):383-391.
Ohsfeldt R, Borisov N, Sheer R. "Fragility Fracture-Related Medical Costs in the First Year Following a Non-Vertebral Fracture in a Managed Care Setting," Osteoporosis Int 2006;17(2):252-258.
Cram, P., Rosenthal, G.E., Ohsfeldt, R.L., Wallace, R.B., Schlechte, J., and Schiff, G.D., “Failure to Recognize and Act on Abnormal Test Results: The Case of Screening Bone Densitometry,” Joint Commission Journal on Quality and Safety, 31 [February 2005]: 90-97.
Ohsfeldt R.L., Ward M.M., Schneider J.E., Jaana M., Miller T.R., Lei Y., Wakefield D.S., "Implementation of Hospital Computerized Physician Order Entry Systems in a Rural State: Feasibility and Financial Impact," Journal of the American Medical Informatics Association, 12 [Jan/Feb 2005]: 394-400.
Ohsfeldt R.L., “Estimating the Cost-Effectiveness of Alternative Treatments for Postmenopausal Osteoporosis,” Expert Review of Pharmacoeconomics & Outcomes Research 4 [December 2004]: 637-44.
Ohsfeldt, R.L., Kreder, K.J., Klein, R.W., and Chrischilles, E.A., “Cost-Effectiveness of Tamsulosin, Doxazosin, and Terazosin in the Treatment of Benign Prostatic Hyperplasia,” Journal of Managed Care Pharmacy, 10 [Sept/Oct 2004]: 412-422.
Ohsfeldt, R.L., Gavin, N.I., and Thorp, J., “Medical Care Costs Associated with Postmenopausal Estrogen Plus Progestogen Therapy,” Value in Health, 7 [Sept/Oct 2004]: 544-553.
Ohsfeldt, R.L., “Challenges in Evaluating the Cost-Effectiveness of Statins,” Journal of Managed Care Pharmacy, 10 [January/February 2004]: 81-82.
Morrisey, M.A., and Ohsfeldt, R.L., “Do State ‘Any Willing Provider’ and ‘Freedom of Choice’ Laws Affect HMO Market Share?” Inquiry, 40 [Winter 2003/2004]: 362-374.
Grabowski, D.C., Ohsfeldt, R.L., and Morrisey, M.A., “The Effects of CON Repeal on Medicaid Nursing Home and Long Term Care Expenditures,” Inquiry 40 [Summer 2003]: 146-157.
Mullins, C.D., and Ohsfeldt, R.L., “Modeling the Annual Costs of Postmenopausal Prevention Therapy Using Hormone Replacement Therapy, Raloxifene, or Alendronate,” Journal of Managed Care Pharmacy, 9 [March/April 2003]: 150-158.
Ohsfeldt, R.L., O’Connor, L.C., Kemner, J.E., and Solomon, T., “Patterns of Physician-Reported Diagnoses Among Women Receiving Prescriptions for Raloxifene,” American Journal of Health-System Pharmacy, 58 [October 1, 2001]: 1846-1849.
Gavin, N.I., Ohsfeldt, R.L., and Thorp, J.E., “Determinants of Hormone Replacement Therapy Duration Among Postmenopausal Women with Intact Uteri,” Menopause, 8 [September 2001]: 377-383.
Hoerger, T., Lakshmanan, M., Lindrooth, R., Plouffe, L., West, S., and Ohsfeldt, R.L., “Health Care Use Among US Women Age 45 and Older: Total Costs and Costs for Selected Postmenopausal Risks,” Journal of Women’s Health & Gender-Based Medicine, 8 [October 1999]: 1077-1089.
Ohsfeldt, R.L., Boyle, R.C., and Capilouto, E.I., “Tobacco Taxes, Smoking Restrictions, and Tobacco Use,” in The Economic Analysis of Substance Use and Abuse: An Integration of Econometric and Behavioral Economic Research, F.J. Chaloupka et al. (eds.), Chicago: University of Chicago Press, for the National Bureau of Economic Research [1999], Chapter 1, pp. 15-30.
Ohsfeldt, R.L., Morrisey, M.A., Nelson, L.J., and Johnson, V., “The Spread of State ‘Any Willing Provider’ Laws,” Health Services Research, 33 [December 1998, Part II]: 1537-1562.
Antel, J.J., Ohsfeldt, R.L., and Becker, E.R., “State Regulation and Hospital Cost Performance,” Review of Economics and Statistics, 77 [August 1995]: 416-422.
Clemmer, R., Kenkel, D., Ohsfeldt, R., and Webb, W., “Household Health Production, Property Values, and the Value of Health,” in Health Values for Policy: An Economic Approach, G. Tolley, D. Kenkel, and R. Fabian (eds.), Chicago: University of Chicago Press [1994], Chapter 5, pp. 105-117.
Ohsfeldt, R.L., “The Effect of AMA Membership on Physicians' Earnings,” Industrial and Labor Relations Review, 42 [October 1988]: 20-33.
Ohsfeldt, R.L., Culler, S.D., and Becker, E.R., “Sex Differences in the Economic Advantages of Physician Board Certification,” Southern Economic Journal, 54 [October 1987]: 343-50.
Ohsfeldt, R.L. and Culler, S.D., “Differences in Income Between Male and Female Physicians,” Journal of Health Economics, 5 [December 1986]: 335-46. |
